Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hour continuous infusion weekly for three weeks in metastatic colorectal carcinoma

✍ Scribed by Richard Pazdur; Diana C. Medgyesy; Rodger J. Winn; S.R. Dakhil; Dennis F. Moore; Anthony Scalzo; Paulo M. Hoff; Susan G. Arbuck; James L. Abbruzzese

• Book ID: 110233503
• Publisher: Springer US
• Year: 1998
• Tongue: English
• Weight: 62 KB
• Volume: 16
• Category: Article
• ISSN: 0167-6997
• DOI: 10.1023/a:1006248700232